Chen Hubert C 4
4 · Metacrine, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Metacrine, Inc.MTCR
Chen Hubert C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-10+90,000→ 90,000 totalExercise: $10.09Exp: 2031-02-09→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on the one year anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter until fully vested on February 10, 2025.